Drugs & medical class action settlements

Acadia Healthcare Personal Injury Class Action

A proposed class action against Acadia Healthcare Company Inc., apparently concerning personal injury claims. The nature of suit is listed as 'P.I.: Other,' suggesting allegations of harm to individuals, but the docket text provides no further details about the specific claims. The case was filed by Kevin Thompson on behalf of a putative class.

Bassett Healthcare Network Personal Injury Class Action

A proposed class action has been filed against Bassett Healthcare Network. The nature of suit is listed as 'P.I.: Other,' suggesting personal injury claims. No further details are available from the docket at this time.

Dexcom Medical Device Class Action

A proposed class action against Dexcom, Inc. was filed in federal court. The docket indicates a personal injury case involving medical devices, though the specific allegations are not detailed in the available caption. The claims appear to concern harm potentially affecting ordinary users of Dexcom products.

Dexcom Personal Injury Class Action

A proposed class action against Dexcom, Inc., apparently concerning personal injuries allegedly caused by one of the company's products, as indicated by the nature of suit for personal injury.

Kovo+ and St. Louis Behavioral Medicine Institute Contract Class Action

A proposed class action lawsuit has been filed against Kovo+ (USA), Inc. and St. Louis Behavioral Medicine Institute, Inc. The complaint, filed by David Ehmcke, appears to involve a contract-related claim, but the specific allegations are not described in the docket text. The case is in its early stages, and no findings or settlement have been reached.

CVS Health Fraud Class Action

A proposed class action was filed against CVS Health Corporation. The case is docketed as 'Other Fraud,' suggesting allegations of fraudulent conduct, but the specific claims are not detailed in the caption or initial docket text. Because this is a newly filed case, the allegations are unproven.

Fresenius Medical Care Fraud Class Action

Tina Centeno filed a proposed class action against Fresenius Medical Care Holdings, Inc., doing business as Fresenius Medical Care North America, asserting claims for fraud. The docket text does not yet contain detailed factual allegations, but the case is docketed under the 'Other Fraud' nature of suit. These are allegations in a newly filed case and have not been proven.

Weightless Medical Class Action

This is a proposed class action against Weightless Medical LLC. The docket metadata indicates the case was filed under 890 Other Statutory Actions, but does not describe the specific allegations. Given the defendant's name, the suit appears to concern medical or health-related products or services, though the exact claims are not specified in the available information.

Pamintuan v. Diana Health Class Action

A proposed class action against Diana Health, Inc. was filed in federal court, apparently concerning personal injury or health-related claims. The nature of suit is listed as 'Other' personal injury, and the case has been designated as related to another proceeding. The specific allegations are not detailed in the available docket entries.

Burns v. McKesson Corporation

This proposed class action names McKesson Corporation as defendant in a personal injury tort matter. Based solely on the caption and nature of suit, the allegations appear to concern some form of personal injury or harmful conduct, though specific details are not available from the docket metadata provided. As McKesson is a major pharmaceutical and healthcare distributor, the claims may relate to drug distribution, medical products, or healthcare services.

Maniscalco v. Boston Scientific Corporation

A proposed class action against Boston Scientific Corporation alleges product liability related to a medical device or pharmaceutical product. The complaint was filed by Anthony Maniscalco and Joseph Mesi, II, and apparently concerns injuries or harm allegedly caused by a Boston Scientific product used by consumers or patients.

Holbrook v. Hims & Hers Health Inc.

This proposed class action against Hims & Hers Health Inc., a telehealth company, alleges unnamed statutory violations. Without access to the complaint details, the specific allegations cannot be determined, but the case appears to involve a consumer or patient dispute with the company.

Metformin Marketing and Sales Practices Settlement

The defendants falsely advertised their generic metformin drugs as equivalent to Glucophage and Glucophage XR, but the drugs were contaminated with NDMA and did not meet FDA standards. Consumers and businesses paid for drugs they would not have purchased had they known the truth. The defendants deny wrongdoing.

Tracleer Litigation Settlement

The defendants allegedly unlawfully delayed the entry of generic formulations of bosentan into the market, causing third-party payors to pay more for brand Tracleer and bosentan than they should have. Defendants deny wrongdoing and there has been no court determination that the allegations were proven or caused harm.

QVAR Antitrust Settlement

Teva allegedly violated antitrust laws by improperly listing patents in the FDA's Orange Book and engaging in product hopping to delay generic competition for QVAR and QVAR Redihaler inhalers, causing consumers and third-party payors to overpay for the brand-name drug. Teva denies all allegations and maintains it did nothing wrong.

Natera Prenatal Testing Settlement

Natera allegedly violated certain laws in connection with sales of its noninvasive prenatal screening tests under the names Panorama or Vasistera. Natera denies any wrongdoing and denies violating any law. The parties agreed to settle to avoid the uncertainties and expenses of continued litigation.

Paid Up to the amount paid out of pocket for the test

Whitman Hospital & Medical Center Data Breach Settlement

Whitman Hospital & Medical Center experienced a data breach between December 26, 2024 and February 28, 2025 that compromised patients' private information. The hospital has agreed to pay $500,000 to settle claims arising from this incident.

Paid $60–$5,000

Sartan Medications Settlement - Valsartan, Losartan, and Irbesartan

Multiple pharmaceutical manufacturers sold blood pressure medications (Valsartan, Losartan, and Irbesartan) that allegedly contained contamination with probable human carcinogens including N-nitrosodimethylamine (NDMA), nitrosamine impurities, and NMBA. The defendants have denied wrongdoing and denied that the contamination amounts were carcinogenic.

Anthem Residential Treatment Coverage Denial Settlement

Anthem denied claims for residential treatment coverage for mental health conditions and substance use disorders, allegedly using medical necessity criteria that were more restrictive than accepted standards of care and the terms of health benefit plans. Anthem denies the allegations but settled to avoid litigation costs and uncertainty.

Paid Amount depends on how many class members submit claims and will likely not be full reimbursement of out-of-pocket expenses. Class members who do not submit claims receive a nominal payment.

Sutter Anesthesia Billing Lawsuit Settlement

Sutter Health allegedly engaged in fraudulent, unlawful, and unfair billing practices by submitting and receiving payment on bills for anesthesia services that were not rendered, were double-billed, or were misleadingly described. This caused self-funded payers to pay more for anesthesia services than they should have. Sutter Health denies all allegations and maintains that its practices complied with applicable laws.

Meta Social Media Harm Settlement with US States

Meta agreed to a settlement with nearly all US states to resolve claims that the company designed Facebook and Instagram to be addictive to teenagers and caused social media harm to young people. Meta denied wrongdoing in the settlement. Under the agreement, Meta will pay up to $18 billion over a decade and limit how teenagers use these platforms.

MultiCare Health System Medication Tampering Settlement

An emergency department nurse at MultiCare Good Samaritan Hospital tampered with injectable pain medications between August 2017 and March 2018, exposing over 2,600 patients to the risk of bloodborne pathogens including Hepatitis B, Hepatitis C, and HIV. MultiCare is accused of negligently hiring and inadequately supervising this employee.

EpiPen (Epinephrine) Pricing Settlement

Mylan Pharmaceuticals and Pfizer engaged in pricing and marketing practices for EpiPens that were allegedly anticompetitive. The defendants are settling claims related to these practices, with total recoveries of $609 million to class members ($345 million from Pfizer and $264 million from Mylan as of February 2022).

Theranos & Walgreens Blood Testing Settlement

Theranos claimed to have revolutionary blood-testing technology that could perform hundreds of health tests with a single pinprick, but the technology did not work. The company partnered with Walgreens to market the product in stores, but thousands of test results were invalidated or called into question. Theranos founder Elizabeth Holmes and COO Ramesh Balwani were criminally convicted for the fraud.

Paid Approximately double their Theranos testing costs, plus approximately $1,000 additional for members of the subclass who participated in Walgreens tiny blood draws